Processa Pharmaceuticals Inc
NASDAQ:PCSA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Processa Pharmaceuticals Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Processa Pharmaceuticals Does
Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. The company is headquartered in Vero Beach, Florida and currently employs 12 full-time employees. The company went IPO on 2013-10-07. The three NGC treatments in its pipeline are NGC-Capecitabine (NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem) and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri) and two non-oncology drug assets are PCS12852, and PCS499.
- Headquarters
- United States of America US
- Employees
- 12
- IPO date
- Oct 7, 2013
